PartneringApril 2026
The Future of Biotech R&D: Why Risk-Sharing Co-Development Models Are Winning
The traditional VC-funded biotech model is being challenged by co-development partnerships where startups and CROs share risk, IP, and milestones. Companies like ProteoGenix are pioneering this approach with computational biotechs.
JFInnova Perspective
JFInnova actively pursues co-development partnerships for JFIN-0001 wet-lab validation (SPR/Biacore, cell assays). We bring the computational IP; partners bring the bench — shared risk, shared upside.
Biotech risk-sharing R&D models